Member Info for W13Ken

Huge news!

NEW YORK, April 22, 2021 - Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) today announced that the United States Government has granted the company a 10-year Governmentwide Acquisition Contract (GWAC) to provide KidneyIntelX early-stage kidney disease bioprognostic™ testing services. The contract, offered through the General Services Administration (GSA), covers laboratory testing services that can be provided through more than 140 U.S. government departments, agencies and affiliates, including the U.S. Veterans Administration (VA), Department of Defense (DoD) military branches (Army, Navy, Air Force, and Marines), and Indian Health Services (IHS). The contract is effective as of April 15, 2021 and has a five-year term with a five-year extension option, and is structured as an Indefinite Delivery, Indefinite Quantity (IDIQ) contract providing for an unlimited quantity of services over the contract term. Under the contract, KidneyIntelX pricing is set at $950 per reportable result.

UiPath shares up 23% to $69 on its first trading day, giving the company a market capitalisation of $35.8bn. Draper investment should now be circa £120m.

Correct me if I'm wrong but have they turned a £10.3m investment into £100m??!!

Fulgent markeg cap $2.6bn.

"Of the publicly traded companies that are small enough to be potential targets, three spring to mind for what they would offer in terms of technology, geography, or both. Bionano Genomics (NASDAQ:BNGO) is a leader in optical genome mapping. Renalytix (NASDAQ:RNLX) uses artificial intelligence for patients with chronic kidney disease, and is based in Europe. Finally, Burning Rock Biotech (NASDAQ:BNR) is a Chinese company that specializes in genetic testing to identify therapies for late-stage cancer patients."

https://www.fool.com/investing/2021/04/20/fulgent-genetics-ceo-just-told-investors-to-look-o/

IBLondon, I think your timing as good as the FY Trading update is on Monday and, for those of us that follow the company closely, they are expected to be strong.

Graphcore is one of the main holdings (maybe #1 holding after some Trustpilot was sold off at the end of March. The recent Edison report is worth a scan. H121 refers to Sept 2020 so values may have increased since then.

"Graphcore: Fabless semiconductor company (core portfolio)
At H121 Draper Esprit had £13.7m invested in Graphcore, with an £80.5m valuation based on the last investment round, representing 5.9x NAV/cash."

https://www.edisongroup.com/publication/a-peek-into-draper-esprits-portfolio/29213/

"FintechOS, a European startup promising a low-code approach to helping financial institutions quickly and painlessly go digital, has raised $60 million in a Series B funding round led by Draper Esprit."

https://www.finextra.com/newsarticle/37884/fintechos-raises-60m/retail

https://www.irishtimes.com/business/companies/draper-esprit-investment-activity-picked-up-in-second-half-of-year-1.4531999

I'm a dedicated long-term holder of GROW in my ISA but this morning have also bought some short-term in my Trading account as I'm so confident they will be near or above 900p by the end of this month.

Very excited for the 26th April Trading Update.

"Two men were killed after a Tesla car crashed into a tree and caught fire in Texas, and police believe there was nobody present in the driver's seat at the time of the accident.

The 2019 Tesla Model S was travelling at a high speed when it failed to negotiate a curve on a winding road.

The victims, both in their 50s, were found in the front passenger seat and in the back of the vehicle.

Tesla did not respond immediately to the BBC's request for comment."

https://www.bbc.co.uk/news/technology-56799749

4D pharma plc (AIM: DDDD; NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces a collaboration with Parkinson's UK, a non-profit organization focused on advancing the understanding of Parkinson's disease and improving treatments, to establish a Patient Advisory Board.

Sage, at least Draper retained a good chunk of Trustpilot so that will benefit the GROW NAV.

There is a Trading Upsate planned for 26th April so I'm expecting the share price to be 900p after that, if not before.

Tripling of revenue in a Covid year! Great rise in the SP today so happy that I topped up on Monday.

Simply Wall Street has a fair value of 561p and that's before these improved results.

Yes, great news. If KidneyIntelX was already delivering 72% better results than other methods then this can only help to make this the essential tool for early detection tool of kidney disease.

Great news Steph. Love this part:

"Goodbody analyst Gerry Hennigan was upbeat about the impact of the flotation for Draper Esprit, noting that it is the equivalent of about a 32p per share uplift to the listed venture capital company. Its shares are also listed in London."

The last paragraph is probably a copy and paste from a previous article as it mentions the sale to Zynga but misses out the significant Trustpilot money.

Good coverage of Draper's latest news in The Irish Tines yesterday and The Times today (behind a paywall).

https://www.thetimes.co.uk/article/draper-esprit-speeds-up-tech-investment-with-128m-spree-39w0rbvsm

From an update in Crowdfund Insider...

"Launched in 2018, Freetrade was founded by CEO Adam Dodds and CMO Viktor Nebehaj. Draper Esprit led the company’s Series A in 2019. This most recent round follows a number of new and follow-on investments from Draper Esprit including Focalpoint, Riverlane, Graphcore and CoachHub."

https://www.crowdfundinsider.com/2021/04/173982-early-crowdfunding-investors-in-uk-fintech-freetrade-have-seen-their-initial-18k-investments-surge-to-over-1m-report/

It's a rare but excellent update Steph. I think the 26th April Trading Update is a month earlier than last year so they can't wait to share the good news with us. A bargain at the current price.

Great to see yesterday's rise. Up to now we haven"t seen too much on the aviation pillar so this article from the Australian Defence Magazine is a real positive.

"A system that tracks eye movements and gaze patterns of pilots-in-training has been installed in No. 79 Squadron’s Hawk 127 Lead-In-Fighter simulator at RAAF Base Pearce, courtesy of Canberra-based company Seeing Machines."

https://www.australiandefence.com.au/news/unique-eye-tracking-system-installed-on-hawk-simulators

One change to Team17's strategic direction, or at least another branch in its direction is the introduction of more upcoming 'non-family' games.

Blasphemous (PEGI 16), the bloodthirsty game with medieval Andalucian Roman Catholic imagery, was released 18 months ago and has recently celebrated 1 million games being sold and has generated an enormous amount of positive feedback for it's art-style and gameplay. Hell Let Loose, the WW2 first-person shooter is PEGI 16 and again gaining really good feedback in Early Access.

Narita Boy is an action-packed retro-style Tron-like PEGI 16 released this week and coming up also are 2 more PEGI 16 games: Thymesia (a dark role-playing game where you play a plague doctor who can turn diseases into physical weapons) and Ready Or Not (where you play a SWAT member in a realistic tactical first person shooter).

This is an interesting turn and although Team17 won't turn their back on the bread and butter of family games, they are getting bolder and more diverse in their game selection.